Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Day One Biopharmaceuticals IncCommon Stock stock | $22.15

Learn how to easily invest in Day One Biopharmaceuticals IncCommon Stock stock.

Day One Biopharmaceuticals Inc. Common Stock is a biotechnology business based in the US. Day One Biopharmaceuticals IncCommon Stock shares (DAWN) are listed on the NASDAQ and all prices are listed in US Dollars. Day One Biopharmaceuticals IncCommon Stock employs 29 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Day One Biopharmaceuticals IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DAWN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Day One Biopharmaceuticals IncCommon Stock stock price (NASDAQ: DAWN)

Use our graph to track the performance of DAWN stocks over time.

Day One Biopharmaceuticals IncCommon Stock shares at a glance

Information last updated 2021-10-10.
Latest market close$22.15
52-week range$17.19 - $28.70
50-day moving average $24.66
200-day moving average $23.03
Wall St. target price$34.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-29.37

Buy Day One Biopharmaceuticals IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Day One Biopharmaceuticals IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Day One Biopharmaceuticals IncCommon Stock price performance over time

Historical closes compared with the close of $22.15 from 2021-10-15

1 week (2021-10-08) 0.54%
1 month (2021-09-17) -4.53%
3 months (2021-07-16) 9.33%
6 months (2021-04-13) N/A
1 year (2020-10-13) N/A
2 years (2019-10-13) N/A
3 years (2018-10-13) N/A
5 years (2016-10-13) N/A

Day One Biopharmaceuticals IncCommon Stock financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value $5.03
Market capitalisation $1.4 billion

TTM: trailing 12 months

Shorting Day One Biopharmaceuticals IncCommon Stock shares

There are currently 1.7 million Day One Biopharmaceuticals IncCommon Stock shares held short by investors – that's known as Day One Biopharmaceuticals IncCommon Stock's "short interest". This figure is 7.4% up from 1.6 million last month.

There are a few different ways that this level of interest in shorting Day One Biopharmaceuticals IncCommon Stock shares can be evaluated.

Day One Biopharmaceuticals IncCommon Stock's "short interest ratio" (SIR)

Day One Biopharmaceuticals IncCommon Stock's "short interest ratio" (SIR) is the quantity of Day One Biopharmaceuticals IncCommon Stock shares currently shorted divided by the average quantity of Day One Biopharmaceuticals IncCommon Stock shares traded daily (recently around 116512.98882682). Day One Biopharmaceuticals IncCommon Stock's SIR currently stands at 14.32. In other words for every 100,000 Day One Biopharmaceuticals IncCommon Stock shares traded daily on the market, roughly 14320 shares are currently held short.

To gain some more context, you can compare Day One Biopharmaceuticals IncCommon Stock's short interest ratio against those of similar companies.

However Day One Biopharmaceuticals IncCommon Stock's short interest can also be evaluated against the total number of Day One Biopharmaceuticals IncCommon Stock shares, or, against the total number of tradable Day One Biopharmaceuticals IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Day One Biopharmaceuticals IncCommon Stock's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Day One Biopharmaceuticals IncCommon Stock shares in existence, roughly 30 shares are currently held short) or 0.1032% of the tradable shares (for every 100,000 tradable Day One Biopharmaceuticals IncCommon Stock shares, roughly 103 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Day One Biopharmaceuticals IncCommon Stock.

Find out more about how you can short Day One Biopharmaceuticals IncCommon Stock stock.

Day One Biopharmaceuticals IncCommon Stock share dividends

We're not expecting Day One Biopharmaceuticals IncCommon Stock to pay a dividend over the next 12 months.

Day One Biopharmaceuticals IncCommon Stock overview

Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California. .

Frequently asked questions

What percentage of Day One Biopharmaceuticals IncCommon Stock is owned by insiders or institutions?
Currently 34.744% of Day One Biopharmaceuticals IncCommon Stock shares are held by insiders and 46.183% by institutions.
How many people work for Day One Biopharmaceuticals IncCommon Stock?
Latest data suggests 29 work at Day One Biopharmaceuticals IncCommon Stock.
When does the fiscal year end for Day One Biopharmaceuticals IncCommon Stock?
Day One Biopharmaceuticals IncCommon Stock's fiscal year ends in December.
Where is Day One Biopharmaceuticals IncCommon Stock based?
Day One Biopharmaceuticals IncCommon Stock's address is: 395 Oyster Point Boulevard, South San Francisco, CA, United States, 94080-1930
What is Day One Biopharmaceuticals IncCommon Stock's ISIN number?
Day One Biopharmaceuticals IncCommon Stock's international securities identification number is: US23954D1090

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site